How many clinical trials are tracked of eplerenone?

19 trials are tracked, 3 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

eplerenone

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of eplerenone

19 trials tracked of eplerenone: 7 in phase 3 or 4 and 3 with published results. The most-cited published study has 183 citations.

19Trials tracked

7Phase 3 & 4

0Recruiting

3With published results

Phase distribution

Phase 4 3 Phase 3 4 Phase 2 4 Phase 1 3 Other / NA 5

Phase 4 Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction Completed · 183 cited
Phase 3 Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy Completed · 64 cited
Phase 3 Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure Completed · 38 cited
Phase 4 EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia Completed
Phase 4 Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone Completed
Phase 3 Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism Completed

Show 13 more trials

Phase 3 A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines Completed
Phase 2 A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension Completed
Phase 2 The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension Completed
Phase 2 A Study of LY2623091 in Male and Females With Chronic Kidney Disease Completed
Phase 2 A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension Completed
Phase 1 Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects Completed
Phase 1 Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance Completed
Phase 1 Pressure Assessment to Improve Outcomes After TAVR: a Registry Completed
N/A Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy Completed
N/A Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study) Completed
N/A Effect of Eplerenone on Postprandial Inflammatory Response in Healthy Adults Completed
N/A Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure) Completed
N/A Hypoglycemia and the Mineralocorticoid Receptor Completed

Showing the 19 most-cited and recently-updated of 19 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.